Navigation Links
Pelosi and Reid Invite President Obama to Address Congress
Date:9/2/2009

WASHINGTON, Sept. 2 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi and Senate Majority Leader Harry Reid sent the following letter today to President Obama inviting him to address a Joint Session of Congress on Wednesday, September 9, 2009.

Below is the text of the letter to the President:

September 2, 2009

President Barack Obama

The White House

Washington, D.C. 20500

Dear Mr. President:

Our nation is closer than ever to achieving health insurance reform that will lower costs, retain choice, improve quality and expand coverage. We are committed to reaching this goal.

We would like to invite you to address a Joint Session of the Congress on Wednesday, September 9, 2009 on health insurance reform.

Thank you for considering this invitation to speak to the Congress and the nation.

Sincerely,

NANCY PELOSI

Speaker of the House

HARRY REID

Majority Leader of the Senate


'/>"/>
SOURCE Office of the Speaker of the House
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Pelosi: SCHIP Bill a Giant Step for Americas Children
2. Pelosi Statement on Proposed Entitlement Task Force
3. Pelosi: Todays Sweeping, Bipartisan Legislation to Improve Drug Safety is a Victory for All Americans
4. Pelosi, Slaughter and Tubbs Jones Introduce Health Tracking Legislation
5. Pelosi: Mr. President - Drop the Partisan Rhetoric, Put Down the Veto Pen
6. Pelosi: Tonights Strong Bipartisan Vote for Childrens Health Insurance a Victory for Americas Children
7. Pelosi Statement on House Vote to Extend Family and Medical Leave for Military Families
8. Pelosi and Reid: Congress Sends President Bush Bipartisan Childrens Health Insurance Bill
9. Pelosi Statement on National Breast Cancer Awareness Month
10. Pelosi: We Remain Committed to Making SCHIP Into Law - With or Without the Presidents Support
11. Pelosi: This Week, Members Must Choose Between Partisan Obstruction and Health Insurance for 10 Million Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article ... obtaining plastic surgery, largely influenced by the growing popularity of “pretty boys” in both ... notes that standards of male appearance are changing not only in the Asian nation, ...
(Date:8/17/2017)... ... 2017 , ... Pot Valet is a leading provider of premium medical-grade cannabis ... state, and soon, every state in the country, the company offers patients safe, legal, ... altogether. , According to Pot Valet, all California patients have the legal ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... Los Angeles, California (PRWEB) , ... August 16, 2017 , ... An August 3rd ... patients that was the subject of a report in JAMA (the Journal of the American ... (BMIs) above 50 were able to achieve BMIs under 30, when compared to patients with ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second ... England student to educate the public on the impact of concussions. Brooke Mills, ... first-ever National Concussion Awareness Day. , Brooke is working diligently is to raise ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology: